Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 4,993 $ 36,589
Restricted cash, current 3,788 3,426
Inventory 5,312 2,954
Prepaids and other current assets 11,410 9,350
Total current assets 25,503 52,319
Property and equipment, net 362,612 311,400
Restricted cash, non-current 10,600 10,600
Operating lease right-of-use assets 37,945 39,331
Deferred warrant asset 50,175 50,175
Deferred battery supplier cost 30,000 30,000
Other non-current assets 5,261 2,647
Total assets 522,096 496,472
Current liabilities    
Accounts payable 84,425 103,187
Accrued expenses and other current liabilities 80,962 63,091
Convertible debt, current 24,979 34,829
Derivative liability, current 4,359 0
Financing liability, current 7,633 0
Warrant liability, current 0 17,171
Total current liabilities 202,358 218,278
Contingent earnout shares liability 449 3,013
Operating lease liabilities 37,308 38,608
Warrant liability, non-current 25,269 0
Financing liability, non-current 23,967 0
Total liabilities 289,351 259,899
Commitments and contingencies (Note 11)
Stockholders’ equity    
Preferred stock, $0.0001 par value; 10,000 authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 1,000,000 and 500,000 authorized as of June 30, 2023 and December 31, 2022, respectively; 568,904 and 355,388 issued and outstanding at June 30, 2023 and December 31, 2022, respectively 56 35
Additional paid-in capital 1,574,114 1,416,361
Accumulated deficit (1,341,425) (1,179,823)
Total stockholders’ equity 232,745 236,573
Total liabilities and stockholders’ equity $ 522,096 $ 496,472